Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2023-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,660	100 Pages	LP Information, Inc.	January, 2023	LPI17669963

Best Price Guarantee
Price	from $3,660
Length	100 Pages
Publisher	LP Information, Inc.
Published Date	January, 2023
SKU	LPI17669963

Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Osteoarthritis Gene Therapy Industry Forecast” looks at past sales and reviews total world Osteoarthritis Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Gene Therapy sales for 2023 through 2029. With Osteoarthritis Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Gene Therapy industry.

This Insight Report provides a comprehensive analysis of the global Osteoarthritis Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoarthritis Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Gene Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Gene Therapy.

The global Osteoarthritis Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Osteoarthritis Gene Therapy players cover Flexion, GeneQuine, Novartis, Smith & Nephew, Genascence, Kolon TissueGene, Sanofi, Paraxel and Medipost, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Gene Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Synovium Injection
Cartilage Injection

Segmentation by application
Hospitals and clinics
Orthopedic Centers
Assisted living Facilities
Nursing Homes
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost
Mundipharma

Please note: The report will take approximately 2 business days to prepare and deliver.

*This is a tentative TOC and the final deliverable is subject to change.*

1 Scope of the Report: 1.1 Market Introduction; 1.2 Years Considered; 1.3 Research Objectives; 1.4 Market Research Methodology; 1.5 Research Process and Data Source; 1.6 Economic Indicators; 1.7 Currency Considered; 1.8 Market Estimation Caveats
2 Executive Summary: 2.1 World Market Overview; 2.1.1 Global Osteoarthritis Gene Therapy Market Size 2018-2029; 2.1.2 Osteoarthritis Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029; 2.2 Osteoarthritis Gene Therapy Segment by Type; 2.2.1 Synovium Injection; 2.2.2 Cartilage Injection; 2.3 Osteoarthritis Gene Therapy Market Size by Type; 2.3.1 Osteoarthritis Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029); 2.3.2 Global Osteoarthritis Gene Therapy Market Size Market Share by Type (2018-2023); 2.4 Osteoarthritis Gene Therapy Segment by Application; 2.4.1 Hospitals and clinics; 2.4.2 Orthopedic Centers; 2.4.3 Assisted living Facilities; 2.4.4 Nursing Homes; 2.4.5 Ambulatory Surgical Centers; 2.4.6 Others; 2.5 Osteoarthritis Gene Therapy Market Size by Application; 2.5.1 Osteoarthritis Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029); 2.5.2 Global Osteoarthritis Gene Therapy Market Size Market Share by Application (2018-2023)
3 Osteoarthritis Gene Therapy Market Size by Player: 3.1 Osteoarthritis Gene Therapy Market Size Market Share by Players; 3.1.1 Global Osteoarthritis Gene Therapy Revenue by Players (2018-2023); 3.1.2 Global Osteoarthritis Gene Therapy Revenue Market Share by Players (2018-2023); 3.2 Global Osteoarthritis Gene Therapy Key Players Head office and Products Offered; 3.3 Market Concentration Rate Analysis; 3.3.1 Competition Landscape Analysis; 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023); 3.4 New Products and Potential Entrants; 3.5 Mergers & Acquisitions, Expansion
4 Osteoarthritis Gene Therapy by Regions: 4.1 Osteoarthritis Gene Therapy Market Size by Regions (2018-2023); 4.2 Americas Osteoarthritis Gene Therapy Market Size Growth (2018-2023); 4.3 APAC Osteoarthritis Gene Therapy Market Size Growth (2018-2023); 4.4 Europe Osteoarthritis Gene Therapy Market Size Growth (2018-2023); 4.5 Middle East & Africa Osteoarthritis Gene Therapy Market Size Growth (2018-2023)
5 Americas: 5.1 Americas Osteoarthritis Gene Therapy Market Size by Country (2018-2023); 5.2 Americas Osteoarthritis Gene Therapy Market Size by Type (2018-2023); 5.3 Americas Osteoarthritis Gene Therapy Market Size by Application (2018-2023); 5.4 United States; 5.5 Canada; 5.6 Mexico; 5.7 Brazil
6 APAC: 6.1 APAC Osteoarthritis Gene Therapy Market Size by Region (2018-2023); 6.2 APAC Osteoarthritis Gene Therapy Market Size by Type (2018-2023); 6.3 APAC Osteoarthritis Gene Therapy Market Size by Application (2018-2023); 6.4 China; 6.5 Japan; 6.6 Korea; 6.7 Southeast Asia; 6.8 India; 6.9 Australia
7 Europe: 7.1 Europe Osteoarthritis Gene Therapy by Country (2018-2023); 7.2 Europe Osteoarthritis Gene Therapy Market Size by Type (2018-2023); 7.3 Europe Osteoarthritis Gene Therapy Market Size by Application (2018-2023); 7.4 Germany; 7.5 France; 7.6 UK; 7.7 Italy; 7.8 Russia
8 Middle East & Africa: 8.1 Middle East & Africa Osteoarthritis Gene Therapy by Region (2018-2023); 8.2 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Type (2018-2023); 8.3 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Application (2018-2023); 8.4 Egypt; 8.5 South Africa; 8.6 Israel; 8.7 Turkey; 8.8 GCC Countries
9 Market Drivers, Challenges and Trends: 9.1 Market Drivers & Growth Opportunities; 9.2 Market Challenges & Risks; 9.3 Industry Trends
10 Global Osteoarthritis Gene Therapy Market Forecast: 10.1 Global Osteoarthritis Gene Therapy Forecast by Regions (2024-2029); 10.1.1 Global Osteoarthritis Gene Therapy Forecast by Regions (2024-2029); 10.1.2 Americas Osteoarthritis Gene Therapy Forecast; 10.1.3 APAC Osteoarthritis Gene Therapy Forecast; 10.1.4 Europe Osteoarthritis Gene Therapy Forecast; 10.1.5 Middle East & Africa Osteoarthritis Gene Therapy Forecast; 10.2 Americas Osteoarthritis Gene Therapy Forecast by Country (2024-2029); 10.2.1 United States Osteoarthritis Gene Therapy Market Forecast; 10.2.2 Canada Osteoarthritis Gene Therapy Market Forecast; 10.2.3 Mexico Osteoarthritis Gene Therapy Market Forecast; 10.2.4 Brazil Osteoarthritis Gene Therapy Market Forecast; 10.3 APAC Osteoarthritis Gene Therapy Forecast by Region (2024-2029); 10.3.1 China Osteoarthritis Gene Therapy Market Forecast; 10.3.2 Japan Osteoarthritis Gene Therapy Market Forecast; 10.3.3 Korea Osteoarthritis Gene Therapy Market Forecast; 10.3.4 Southeast Asia Osteoarthritis Gene Therapy Market Forecast; 10.3.5 India Osteoarthritis Gene Therapy Market Forecast; 10.3.6 Australia Osteoarthritis Gene Therapy Market Forecast; 10.4 Europe Osteoarthritis Gene Therapy Forecast by Country (2024-2029); 10.4.1 Germany Osteoarthritis Gene Therapy Market Forecast; 10.4.2 France Osteoarthritis Gene Therapy Market Forecast; 10.4.3 UK Osteoarthritis Gene Therapy Market Forecast; 10.4.4 Italy Osteoarthritis Gene Therapy Market Forecast; 10.4.5 Russia Osteoarthritis Gene Therapy Market Forecast; 10.5 Middle East & Africa Osteoarthritis Gene Therapy Forecast by Region (2024-2029); 10.5.1 Egypt Osteoarthritis Gene Therapy Market Forecast; 10.5.2 South Africa Osteoarthritis Gene Therapy Market Forecast; 10.5.3 Israel Osteoarthritis Gene Therapy Market Forecast; 10.5.4 Turkey Osteoarthritis Gene Therapy Market Forecast; 10.5.5 GCC Countries Osteoarthritis Gene Therapy Market Forecast; 10.6 Global Osteoarthritis Gene Therapy Forecast by Type (2024-2029); 10.7 Global Osteoarthritis Gene Therapy Forecast by Application (2024-2029)
11 Key Players Analysis: 11.1 Flexion; 11.1.1 Flexion Company Information; 11.1.2 Flexion Osteoarthritis Gene Therapy Product Offered; 11.1.3 Flexion Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.1.4 Flexion Main Business Overview; 11.1.5 Flexion Latest Developments; 11.2 GeneQuine; 11.2.1 GeneQuine Company Information; 11.2.2 GeneQuine Osteoarthritis Gene Therapy Product Offered; 11.2.3 GeneQuine Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.2.4 GeneQuine Main Business Overview; 11.2.5 GeneQuine Latest Developments; 11.3 Novartis; 11.3.1 Novartis Company Information; 11.3.2 Novartis Osteoarthritis Gene Therapy Product Offered; 11.3.3 Novartis Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.3.4 Novartis Main Business Overview; 11.3.5 Novartis Latest Developments; 11.4 Smith & Nephew; 11.4.1 Smith & Nephew Company Information; 11.4.2 Smith & Nephew Osteoarthritis Gene Therapy Product Offered; 11.4.3 Smith & Nephew Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.4.4 Smith & Nephew Main Business Overview; 11.4.5 Smith & Nephew Latest Developments; 11.5 Genascence; 11.5.1 Genascence Company Information; 11.5.2 Genascence Osteoarthritis Gene Therapy Product Offered; 11.5.3 Genascence Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.5.4 Genascence Main Business Overview; 11.5.5 Genascence Latest Developments; 11.6 Kolon TissueGene; 11.6.1 Kolon TissueGene Company Information; 11.6.2 Kolon TissueGene Osteoarthritis Gene Therapy Product Offered; 11.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.6.4 Kolon TissueGene Main Business Overview; 11.6.5 Kolon TissueGene Latest Developments; 11.7 Sanofi; 11.7.1 Sanofi Company Information; 11.7.2 Sanofi Osteoarthritis Gene Therapy Product Offered; 11.7.3 Sanofi Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.7.4 Sanofi Main Business Overview; 11.7.5 Sanofi Latest Developments; 11.8 Paraxel; 11.8.1 Paraxel Company Information; 11.8.2 Paraxel Osteoarthritis Gene Therapy Product Offered; 11.8.3 Paraxel Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.8.4 Paraxel Main Business Overview; 11.8.5 Paraxel Latest Developments; 11.9 Medipost; 11.9.1 Medipost Company Information; 11.9.2 Medipost Osteoarthritis Gene Therapy Product Offered; 11.9.3 Medipost Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.9.4 Medipost Main Business Overview; 11.9.5 Medipost Latest Developments; 11.10 Mundipharma; 11.10.1 Mundipharma Company Information; 11.10.2 Mundipharma Osteoarthritis Gene Therapy Product Offered; 11.10.3 Mundipharma Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023); 11.10.4 Mundipharma Main Business Overview; 11.10.5 Mundipharma Latest Developments
12 Research Findings and Conclusion